Professor Tarik Kivrak
Firat University, Elazig (Turkiye)
Membership:
FESC Member
HFA Member
Biography
Name Surname: Tarik Kivrak
Address: Firat University Hospital, Cardiology Department, Elazig, Turkey
Phone: (+90 0505 372 99 45)
E-Mail: tarikkivrak@gmail.com
Born: July 8, 1982 – Adana-Turkey
Education: Ondokuz Mayıs University Medical School, Samsun, Turkey (2000-2006). Marmara University Medical School, Cardiology Education, İstanbul, Turkey(2008-2013)(Medical Doctor), Sivas Numune Hospital, Cardiology Specialist, Sivas, Turkey(2013-2017)(Cardiology Specialist), University of Firat, Department of Cardiology, Elazig, Turkey(2017-Now)(Ass.Prof), Alma Mater Studiorum Universita Di Bologna, Pulmonary Vascular Disease, Master Degree Programme, Bologna, Italy(2018-2019)
My Clinical Interests: Pulmonary Arterial Hypertension, Chronic Pulmonary Thromboembolism, Heart Failure , Artificial Intelligence
My Association Membership : European Society of Cardiology, ESC Heart Failure Association, Turkish Society of Cardiology, Cardiovascular Academy Association, Lung-Vessel Diseases Ass
Contributor content
Presentation
Clinical characteristics of patients with chronic heart failure and reduced, mildly-reduced, preserved, and improved ejection fraction: an analysis of the turkiye heart failure (TURK-HF) registry
Presentation
Translational application of a self-organized deep feature engineering pipeline for non-invasive pulmonary hypertension classification from routine chest radiographs
Presentation
Clinical characteristics and in-hospital outcomes of patients with acute heart failure: baseline results from the turkiye heart failure (TURK-HF) registry
Presentation
Clinical management strategies of cardiologists in heart failure with reduced ejection fraction
Presentation
Pulmonary hypertension classification based on machine learning using standart chest X-ray:ATA artificial intelligence study-1
Presentation
Artificial intelligence for prediction of pulmonary arterial hypertension detection using computer tomography
Presentation
The prevalence and clinical features of atrial fibrillation in heart failure patients with midrange ejection fraction in the Turkish population
Presentation
Acute Effect of Sacubitril/Valsartan on Depression Score in patients with Acute Decompansed Heart Failure on the First Day of Theraphy:A Prospective Analysis from Our Center Experiences
Presentation
Review of the protective effects of Compound 21 and valsartan in iso-induced heart failure in rats
Presentation
